1832 Asset Management’s WisdomTree BioRevolution Fund WDNA Stock Holding History

1832 Asset Management’s Portfolio WDNA Stock Details WDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,640	Closed	-$55.1K	–	915
2023 Q3	$55.1K	Hold	3,640	–	–	﹤0.01%	689
2023 Q2	$63.4K	Hold	3,640	–	–	﹤0.01%	691
2023 Q1	$62.5K	Hold	3,640	–	–	﹤0.01%	719
2022 Q4	$63.2K	Hold	3,640	–	–	﹤0.01%	748
2022 Q3	$61K	Hold	3,640	–	–	﹤0.01%	725
2022 Q2	$63K	Hold	3,640	–	–	﹤0.01%	736
2022 Q1	$73K	Buy	3,640 +1,200	+49%	+$24.1K	﹤0.01%	770
2021 Q4	$58K	Buy	+2,440	New	+$60K	﹤0.01%	579

Other funds holding WDNA

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

1832 Asset Management's WDNA Position: Q4 2023 in Review

1832 Asset Management sold out of WisdomTree BioRevolution Fund (WDNA) in Q4 2023, closing a stake of 3,640 shares — an estimated $55.1K sold.

1832 Asset Management first reported a position in WDNA in Q4 2021 and held it in 8 quarters. The position peaked at $73K in Q1 2022. 3 funds tracked by Wall St. Rank hold WDNA as of Q4 2023.

1832 Asset Management reported no remaining WisdomTree BioRevolution Fund position as of Q4 2023 after selling out during the quarter.
1832 Asset Management sold 3,640 WisdomTree BioRevolution Fund shares in Q4 2023, an estimated $55.1K.
1832 Asset Management first reported a position in WisdomTree BioRevolution Fund in Q4 2021 and held it in 8 quarters.
1832 Asset Management's WisdomTree BioRevolution Fund position peaked at $73K in Q1 2022.
3 funds tracked by Wall St. Rank held WisdomTree BioRevolution Fund as of Q4 2023.

Based on 1832 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.